Article: WYETH-AYERST LABORATORIES RESPONDS TO SENATE AGING COMMITTEE REPORT

 
PHILADELPHIA, Feb. 3 /PRNewswire/ -- The following was released today by Wyeth-Ayerst Laboratories in response to a U.S. Senate Aging Committee report: 
Although American Home Products' (NYSE: AHP) pharmaceutical division Wyeth-Ayerst has not been identified as having reneged on any pricing commitments, we believe it is important to correct the are the facts about Wyeth-Ayerst products. 
Wyeth-Ayerst Laboratories will maintain its commitment with respect to its pricing policy for pharmaceuticals.  The company recently committed to holding drug prices to the CPI for 1993.  On March 5, 1992, AHP told security analysts that drug price increases were expected to be at 4 ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!